What Are Minor Cannabinoids?

A Beginner’s Guide to Minor Cannabinoids like CBN, CBG, CBC, and More

You’ve probably heard of THC and CBD, the most popular cannabinoids of the cannabis world. But did you know that the cannabis plant contains over 100 different cannabinoids? Most of them don’t get nearly as much attention, but that doesn’t mean they aren’t important. These lesser-known compounds are called minor cannabinoids.

Think of the cannabis plant like a band. THC and CBD are the lead singer and guitarist. Everyone knows them. But behind them is a whole crew of musicians playing instruments you might not even recognize yet. Without them, the song just wouldn’t be the same.

So, what are minor cannabinoids? Let’s break it down. No science degree required.

Major Cannabinoids, Minor Cannabinoids, and Everything In Between

Here’s something most people don’t know: cannabis doesn’t actually make THC or CBD directly. Instead, the plant first produces cannabinoid acids. Those acids then convert into the active cannabinoids we know when heat is applied, through a process called decarboxylation. This is why smoking, vaping, or cooking cannabis activates its effects. Without heat, you’re mostly working with the raw, acidic forms of these compounds.

All cannabinoids are classified by one simple rule: how much of them the plant actually produces.

Major cannabinoids like THC and CBD are present in the largest concentrations and are the most studied. In cannabis, CBD can account for up to 40% of the plant extract.

Minor cannabinoids such as CBN, CBG, and CBC exist in much smaller, rarer quantities. For example, after a cannabis plant converts most of its CBG into other compounds during growth, only about 1% CBG remains in the mature plant. That scarcity is one reason the minors have taken longer to research and produce at scale.

The Three Types of Cannabinoids: Acidic, Neutral, and Varinic

Cannabinoids fall into three main categories: acidic, neutral, and varinic, each playing a different role in how cannabis affects the body.

Acidic cannabinoids are the natural, raw compounds found in the living plant (like THCA, CBDA, and CBGA). They are non-intoxicating and serve protective functions for the plant. When heat is applied, they undergo decarboxylation, converting into active forms.

Neutral cannabinoids (THC, CBD, CBG, etc.) are the activated compounds created through heat. These interact with the body’s endocannabinoid system and produce the effects consumers experience. THC is the primary psychoactive cannabinoid, while most others are non-intoxicating.

Varinic cannabinoids (like THCV and CBDV) are rarer compounds with a slightly different chemical structure. They may offer unique effects and are an emerging focus in cannabis research and cultivation.

Key takeaway: All cannabinoids begin in their acidic form. Whether they remain raw, become activated, or exist as varinic compounds determines their effects—making this a foundational concept in cannabis science.

The Top Two Major Cannabinoids

THC (Tetrahydrocannabinol)

THC is the cannabis plant’s primary psychoactive component. Once absorbed into the bloodstream, it travels to areas of the brain responsible for thinking, memory, pleasure, coordination, and movement. Beyond its psychoactive effects, THC is being studied for its potential to address chronic pain, reduce nausea, stimulate appetite, aid sleep, manage glaucoma, and reduce muscle spasms. New users are generally advised to start at a very low dose (around 2.5 to 5 mg) and increase gradually.

CBD (Cannabidiol)

CBD is non-psychoactive and was the first cannabinoid ever discovered. It has shown promise for anti-anxiety, anti-inflammatory, pain reduction, and antipsychotic applications. The only FDA-approved cannabinoid-based therapy on the market is Epidiolex, a CBD medication for certain forms of epilepsy. Research into broader uses is actively ongoing. Notably, CBD can also reduce THC’s intoxicating side effects, like anxiety, by modulating how THC interacts with CB1 receptors in the brain.

Research momentum on minor cannabinoids is accelerating fast. According to a PubMed database analysis cited by Emergen Research, peer-reviewed publications on minor cannabinoids increased by 340% between 2020 and 2024, with CBG studies leading the charge. 

Other Minor Cannabinoids

Let’s introduce you to some of the most talked-about minor cannabinoids. Think of this as your “meet the band” moment.

CBN (Cannabinol): The Sleepy One

CBN is formed when THC ages and breaks down over time. So if you’ve ever left cannabis sitting around for a while, it might have more CBN in it than when it was fresh.

CBN is mildly psychoactive (much less so than THC), but it’s most famous for its potential sedative properties. Some people use CBN-infused products to help them sleep, though more research is still needed to confirm just how effective it is.

Remember it as: CBN = “Can’t Be awake at Night.” It’s the sleepy cannabinoid.

CBG (Cannabigerol): The Mother of All Cannabinoids

CBG is often called the “stem cell” or “mother” of cannabinoids, because many other cannabinoids (including THC and CBD) actually start out as CBG before the plant converts them.

Because so much CBG gets converted into other cannabinoids, it’s typically found in very small amounts in mature plants, which makes it expensive to produce. Research suggests CBG may have anti-inflammatory, antibacterial, and neuroprotective properties, making it one of the most exciting minor cannabinoids to study.

Remember it as: CBG = “Cannabis Baby Grandparent.” It’s the original cannabinoid from which others are born.

CBC (Cannabichromene): The Quiet Achiever

CBC doesn’t get a lot of press, but scientists are paying attention. It’s non-psychoactive (meaning it won’t get you high) and is believed to work best when combined with other cannabinoids, a concept called the entourage effect (more on that in a minute).

Early research suggests CBC may support brain health, mood, and pain management. It’s also being studied for its potential anti-inflammatory properties.

Remember it as: CBC = “Can Boost Cognition.” It’s the brain-friendly one.

THCV (Tetrahydrocannabivarin): The Appetite Suppressor

THCV is structurally similar to THC, but it behaves very differently. At low doses, it actually blocks some of THC’s effects. At higher doses, it may produce its own mild psychoactive effects.

What’s really interesting about THCV is its potential as an appetite suppressant, which is the opposite of THC’s famous “munchies” effect. It’s also being studied for its potential role in blood sugar regulation.

Remember it as: THCV = “THC’s Veggie-loving cousin.” It says no to the munchies.

CBDA & THCA: The Raw Versions

Before cannabis is heated (through smoking, vaping, or cooking), THC and CBD actually exist in their “acid” forms: THCA and CBDA. These raw forms are non-psychoactive on their own.

When you apply heat, through a process called decarboxylation. When that happens, THCA converts to THC and CBDA converts to CBD. Raw cannabis juices and unheated products retain these acid forms, which are being studied for their own therapeutic potential.

Remember it as: Add heat → activate. No heat → stay acidic (and non-psychoactive).

The Entourage Effect

The entourage effect is the idea that cannabinoids work better together than they do alone. Think of it like a sports team: one great player is good, but a full team that works together is even better. When CBN, CBG, CBC, and other minor cannabinoids are present alongside THC and CBD, they may enhance each other’s effects and reduce unwanted side effects.

This is one reason why whole-plant cannabis products (also called “full-spectrum” products) are popular because they contain a wider range of cannabinoids, including the minors.

Where Are Minor Cannabinoids Found?

Minor cannabinoids are naturally present in the cannabis plant, but in much smaller concentrations than THC and CBD. You can find them in:

• • Full-spectrum CBD and cannabis products
  • Specialized hemp extracts bred to be high in CBG or CBC
  • Raw cannabis or hemp juice (for THCA and CBDA)
  • Isolate products specifically made with a single minor cannabinoid (like CBN sleep gummies)

As cannabis science advances, more growers are cultivating strains specifically designed to produce higher quantities of minor cannabinoids.

Are Minor Cannabinoids Legal?

This is where it gets a little tricky, which is exactly why cannabis education matters so much. The legal status of minor cannabinoids depends on where they come from and where you live.

For example:

• • Minor cannabinoids derived from hemp (containing less than 0.3% THC) are generally legal under the 2018 Farm Bill in the U.S.
  • Minor cannabinoids from marijuana plants may fall under state cannabis regulations
  • Laws vary widely by state and country, so always check your local regulations

The cannabis industry is constantly evolving, and regulations change frequently. Staying educated is essential for consumers, patients, and especially cannabis industry professionals.

What Does the Research Say?

Minor cannabinoid research is still in its early stages. Most studies have been conducted in labs or on animals, with limited large-scale human clinical trials. That said, the early findings are promising:

• • CBN shows potential as a sleep aid and anti-inflammatory agent
  • CBG is being studied for its effects on conditions like glaucoma, IBS, and Huntington’s disease
  • CBC may support neurogenesis (the growth of new brain cells) and has shown antidepressant properties in early studies
  • THCV is being explored for its potential in managing obesity and Type 2 diabetes

The key message? We are just beginning to scratch the surface. The more we learn about what minor cannabinoids are and how they work, the more opportunities there will be for medicine, wellness, and the cannabis industry. And the market reflects that excitement: according to Grand View Research, the U.S. minor cannabinoids market was valued at $14.55 billion in 2024 and is projected to reach nearly $59.38 billion by 2034, growing at a compound annual growth rate of 15.1%. That’s not a niche trend. That’s a booming industry that will need knowledgeable professionals.

Want to Turn Your Cannabis Curiosity Into a Career?

Understanding minor cannabinoids isn’t just for cannabis connoisseurs. It’s essential knowledge for anyone working in or entering the cannabis industry.

At Cannabis Career Academy, our online cannabis certification courses are designed to give you a deep, practical understanding of the cannabis plant, covering everything from the endocannabinoid system and cannabinoid chemistry to regulations, dispensary operations, and career pathways.

Whether you’re starting out as a budtender, a wellness professional, or an entrepreneur ready to launch a cannabis business, our curriculum was built for you; 100% online, self-paced, and regularly updated to keep up with this fast-moving industry.

FAQs: What Are Minor Cannabinoids?

Are minor cannabinoids psychoactive?

Most minor cannabinoids are non-psychoactive or only mildly so. THCV can be mildly psychoactive at higher doses, and CBN has very mild psychoactive effects, but nothing like THC.

Can I buy products with minor cannabinoids?

Yes! Many hemp-derived products now specifically highlight minor cannabinoids like CBN, CBG, and CBC. Always check the source (hemp vs. marijuana) and your local laws before purchasing.

Do minor cannabinoids show up on drug tests?

This depends on the specific cannabinoid and the type of test. Some minor cannabinoids can trigger a positive result on THC-focused tests. When in doubt, consult your employer’s drug testing policy before using any cannabinoid product.

Where can I learn more about minor cannabinoids?

Cannabis Career Academy’s online certification courses cover cannabinoid science in depth, including how minor cannabinoids interact with the endocannabinoid system. Enroll today and get certified in 10 hours or less!